. EIAV is a retrovirus of the lentivirus subgroup whose other family members include the human and simian immunodeficiency viruses (HIV and SIV), visna virus, caprine arthritis-encephalitis virus, and the recently described lentiviruses feline immunodeficiency virus (FIV) (35) and bovine immunodeficiency virus (15). Most of these viruses are known to encode several genes in addition to those required for replication and virion assembly; in some of these viruses, these gene products function as regulators of virus expression.
Equine infectious anemia virus (EIAV) is the etiologic agent of a disease of horses that is characterized by severe anemia, fever, and viremia in a periodically cycling manner (5) . The virus infects cells of the monocyte/macrophage lineage and persists for the life of the animal; stress or immunosuppression may precipitate a resumption of clinical disease (25, 29) . EIAV is a retrovirus of the lentivirus subgroup whose other family members include the human and simian immunodeficiency viruses (HIV and SIV), visna virus, caprine arthritis-encephalitis virus, and the recently described lentiviruses feline immunodeficiency virus (FIV) (35) and bovine immunodeficiency virus (15) . Most of these viruses are known to encode several genes in addition to those required for replication and virion assembly; in some of these viruses, these gene products function as regulators of virus expression.
The control of gene expression has been extensively examined for the primate immunodeficiency viruses and visna virus. These agents appear to control their expression through a complex interaction of viral regulatory proteins and cis-acting response elements. The first of several regulatory proteins to be described for these viruses was the HIV transcriptional activator, Tat, which acts in concert with sequence elements in the long terminal repeats (LTRs) to increase the abundance of viral transcripts (2, 40, 43, 44) . The HIV and SIV Tat proteins share several highly conserved amino acid domains and act on Tat-response (TAR) elements located downstream of the RNA start site (36, 45) . In contrast, the sequence of the visna virus Tat protein is quite different from those of the primate virus Tat proteins and appears to act on sequence elements located in a region upstream from the transcriptional promoter (8, 22) . It issince the EIAV TAR elements were present in the region immediately downstream of the RNA start site (9, 11) . On the basis of the mechanistic similarities, we hypothesized that EIAV might encode a Tat protein related to the HIV and SIV proteins. A putative tat gene has been mapped to the central region of the EIAV genome both by deletion analyses of the provirus (42) and by cloning subgenomic fragments into mammalian expression vectors (11) . Because there were several open reading frames (ORFs) and potential splice sites within the region tested, an unambiguous definition of the essential tat exon was not possible. In the work de- scribed in the present communication, we examined the sequence and expression of the EIAV tat gene and analyzed the structure and activity of the Tat protein in transfected cells. The (11). RESULTS Identification of the essential tat exon. As a first step in identifying the EIAV tat gene, genomic fragments derived from the central region of the virus genome were expressed in mammalian cells (11) . EIAV tat coding sequences were thus mapped to an 800-bp fragment that contained the 3' end of the pol gene, two small ORFs designated Si and S2, and the 5' end of the env gene (Fig. 1) . EIAV LTR-directed transcription was activated in cells transfected with the expression plasmid pS1,2, which contains this 800-bp NcolSmaI fragment controlled by the SV40 early promoter (11) . To precisely identify the ORF required for the expression of Tat activity, we have introduced several deletions and point mutations into pS1,2 ( Fig. 1) To identify and characterize the tat mRNA, we constructed a cDNA library from poly(A)+ RNA from the E-FEA cell line. It was known from earlier transfection experiments that this cell line produces significant Tat activity (9, 11) . Of approximately 40 ,000 recombinant plaques, 5 clones, whose inserts ranged in size from 0.4 to 4.0 kb and showed positive hybridization to a probe containing ORFs Si and S2, were examined by nucleotide sequencing. Of these five clones, two appeared to represent truncated copies of unspliced RNAs and the other three, designated 492, 272, and 442, were examined in detail. Their basic features are summarized in Fig. 2B . Clone 492 appears to represent a nearly complete copy of a multiply spliced RNA, since 5 (9) . Exon 1 (bases numbered 1 to 236 in Fig. 3) contains the R and U5 regions of the 5' LTR and 130 nucleotides of the region preceding the gag gene. This is joined to exon 2 by a splice donor immediately before the gag initiation codon and a splice acceptor in ORF Si (genome positions 440 and 5116, respectively) (24, 37 (Fig. 3) Si, it is presumed to represent the tat mRNA. The second extended ORF, of 160 codons, follows the stop codon at the end of ORF Si. Thus, exon 3 is read for 105 codons in ORF S3; then the reading frame shifts relative to the genomic sequence (due to a single base deletion at position 836 of the cDNA) and continues for an additional 55 codons in the env ORF. By analogy to the primate lentiviruses, it is possible that this ORF encodes a rev gene.
The inferred amino acid sequence of EIAV Tat is compared with that of Tat proteins of other lentiviruses in Fig. 4 Table 2 ), suggesting that cDNA clone 492 represents an authentic tat mRNA. Expression plasmids containing cDNA from clones 442 and 272 yielded levels of Tat activity comparable to those of pRS492 (data not shown). A series of plasmids was then constructed in which fragments from cDNA clone 492 were inserted into the expression plasmid pRSPA to define the region containing the translation initiation codon (Fig. 5A) . The first plasmid in this series, pRS-Etat-HA, contains the two tat coding exons located between the HaeII and ApaI sites (Fig. 3, positions 111 to 390). A translation termination codon was introduced at the SmaI site of pRS-Etat-HA to create the plasmid pRSEtat-HAX. Expression of Tat activity in cells transfected with pRS-Etat-HA and pRS-Etat-HAX was compared over a range of DNA concentrations ( Fig. 6; Table 2 ). pRS-Etat-HA activated EIAV LTR-controlled CAT expression even at the lowest concentration tested (1 ng), whereas pRSEtat-HAX was relatively inactive. Plasmid pRS-Etat-S is deleted of sequences upstream from the SmaI site (Fig. 5A ) and was also inactive in the cotransfection experiments (Table 2) . Together, these data suggested that tat translation is initiated between the stop codon at position 123 and the SmaI site at position 170 of the cDNA. The cDNA fragment from the plasmid pRS-Etat-S was fused to a methionine initiation codon in a related vector to give pRS-Etat-M; this plasmid expressed Tat activity, indicating that sequences upstream of the SmaI site are required for translation initiation but are not essential for Tat function. Within this region of exon act as alternative initiation codons in other systems (34) ; these include the CUG at position 141, UUG at 144, CUG at 150, and AUC at 165 of the cDNA sequence (Fig. 3) . The CUG at 150, followed by the AUC at 165, would be predicted to be the most efficiently utilized start codons based on the Kozak consensus sequence context (26) . The precise identification of the tat start codon is currently being addressed by site-directed mutagenesis.
The preceding experiments indicated that the region upstream of the SmaI site supplies the translation initiation codon but does not contain amino acids essential for Tat function. To define the essential N-terminal amino acids, cDNA fragments with progressive deletions of 5' sequences were ligated to expression plasmids that supply a translation initiation codon (Fig. SB) . Plasmid pRS-Etat-B was deleted of sequences upstream from the BstNI site (position 216) and did not express Tat activity. When this fragment was ligated to a vector that provides a methionine initiation codon, pRS-Etat-MB, Tat activity was expressed at high levels in transfected cells (Table 2) . pRS-Etat-M25 lacks the entire exon 1 and 4 residues of exon 2 of tat and still expressed Tat activity in transfected cells. pRS-Etat-M24 is missing an asparagine and a tyrosine residue at the start of the core domain; this deletion reduced Tat activity by approximately 60%. Removal of the tyrosine and histidine at the N terminus of the core domain in plasmid pRS-Etat-M23 reduced Tat activity by 97%. Plasmid pRS-Etat-MP, which lacks the first 4 residues of the core region, did not express Tat activity. Thus, a non-AUG codon present in exon 1 is used for initiation of EIAV tat translation; however, other amino acids in exon 1 are not required for Tat function. Tat activity was reduced when the first two residues of the core domain were removed and abolished when the first four residues were deleted. These results support the domain topography (4) , and SIVagm (14) . Visna virus Tat is based on the sequence of Davis and Clements (8) . For FIV, the deduced amino acid sequence is that of ORF 2, analogous to visna virus ORF S (tat), from FIV-14 (32) . The sequence for EIAV Tat assumes that translation is initiated at the CUG codon at position 150 of cDNA 492. The boxed sequences, from left to right, correspond to the cysteine-rich, core, and basic domains; these are contiguous regions that are separated in the figure for emphasis.
primate COS cells, and human HeLa cells transfected with plasmids that expressed EIAV or HIV-1 Tat was compared ( Table 3 ). The HIV-1 tat gene was cloned into the expression plasmid pRSPA to give pRS-Htat; plasmid pCl5cat contains an HIV-1 LTR-controlled cat gene (40) . Two different EIAV Tat expression plasmids were tested with pEIcat; pRSEtat-HA has the native non-AUG start codon, whereas pRS-Etat-M has a synthetic methionine initiation codon (Fig. 5A) . The plasmids yielded nearly identical levels of Tat activity in all cell lines examined, indicating that the non-AUG start codon is utilized in cells other than D17. The ability of either HIV-1 or EIAV Tat to trans-activate the (Fig. 3) . Asterisks denote stop codons in the cDNA. The splice site is shown, indicating the sequences derived from exons 1 and 2; the two conserved domains are represented as boxes. Potential alternative initiation codons are indicated by CUG and AUC. Restriction enzyme sites are HaeII (H), SmaI (S), BstNI (B), PvuII (P), and ApaI (A).
Restriction fragments from cDNA 492 were cloned into the expression plasmid, pRSPA, to give the series of plasmids starting with pRS-Etat-HA. Plasmid pRS-Etat-HAX has an oligonucleotide containing a stop codon inserted at the SmaI site. The fragments preceded by (Met) were cloned into vectors that supply an in-frame translation initiation codon. (B) Predicted N-terminal amino acid sequences of Tat proteins expressed from plasmids containing cDNA fragments fused to a methionine initiation codon. The two Tat-encoding exons are indicated. The core domain is boxed, and the C terminus of Tat is not shown. In pRS-Etat-M25, the vector donates Met and Pro residues; in pRS-Etat-M24, the vector supplies the N-terminal Met, Asp, Pro, and Pro residues; in pRS-Etat-M23, only the N-terminal Met is derived from the vector.
transfected cells and in cell-free systems (34) . Furthermore, several eucaryotic and viral proteins, including human basic fibroblast growth factor (13), a second product of the human c-myc gene (19) , a mouse mutant dhfr gene (33) EIAV Tat sequence, since it does not have the latter domain. The absence of the cysteine-rich domain in EIAV Tat suggests that it may not be required for trans-activation by the other Tat proteins. That this region may play an auxiliary role, perhaps in modulating Tat activity by altering protein conformation, is supported by the experimental observations that HIV-1 Tat peptides lacking the cysteine-rich region possessed Tat activity (17), whereas activity was lost when specific amino acids within this domain were altered (38) . By using synthetic peptides, it was revealed that the minimal, active HIV-1 Tat peptide contained the core and basic domains (16, 17) , consistent with the conservation of these regions among the divergent viruses. Removal of the four N-terminal amino acids of the EIAV Tat core domain abolished activity, whereas the minimal, active HIV-1 Tat peptides lack six N-terminal residues from this domain (16) . This discrepancy may reflect differences in the Tat proteins, cell lines, or experimental approaches used. The basic domain has been shown to be required for HIV-1 Tat activity and nuclear localization (21) . Although it is hypothesized to act in nucleic acid binding (16) , the role of this and other domains in trans activation is not known. The distinct TAR and cell type specificities of EIAV and HIV Tat proteins, combined with their modular domain structures, suggest that chimeric EIAV-HIV Tat proteins may be useful in analyzing the function of each region in the trans-activation process. Evolution of lentivirus Tat proteins. The similarity of the cis-and trans-acting components of the EIAV Tat system to the primate lentiviruses but not to visna virus or FIV is paradoxical in light of the lentivirus phylogenies derived from nucleotide sequence comparisons of pol genes (10, 28) . These phylogenies would generally place EIAV closer to visna virus and FIV than to the primate lentiviruses. Moreover, EIAV, visna virus, and FIV contain a proteaselike gene segment, inserted between the RNase H-and endonuclease-encoding regions of the pol gene, that is not present in HIV or SIV (27) . It was suggested that the gene segment was captured after the divergence of an EIAV, FIV, and visna virus ancestor from the primate lentivirus progenitor. The alternative possibility, that the ancestor of HIV and SIV lost this gene segment, is supported by the relationship of EIAV to the other lentiviruses based on the comparison of the trans-activation components. EIAV trans activation is more similar to that of HIV and SIV than to that of the nonprimate lentiviruses. The position of the tat (and perhaps rev) exons in the genome and the splicing patterns that are used to generate the tat mRNA are very similar in all the lentiviruses examined in detail, suggesting that these genes were present before the divergence of EIAV, HIV, SIV, FIV, and visna virus. It is possible that recombination events have led to mixing or that FIV and visna virus independently evolved trans activators of a different type from those of EIAV, HIV, and SIV. As more and different lentiviruses are examined, perhaps a clearer picture of the evolution of regulatory function in lentiviruses will emerge.
